SGLT2 inhibitors represent one of the most transformative developments in diabetes medicine in the past decade. Originally approved as glucose-lowering agents, these medications have since demonstrated remarkable protective effects on the heart and kidneys — benefits so significant that they are now recommended for people with heart failure and chronic kidney disease even in the…
English 
Urdu